Efficacy and tolerability of tolterodine in children with detrusor hyperreflexia-Reference-Cited by-同舟云学术

Efficacy and tolerability of tolterodine in children with detrusor hyperreflexia

Published:2000-03 Issue:3 Volume:55 Page:414-418
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Goessl Carsten,Sauter Thomas,Michael Theodor,Bergé Bernd,Staehler Michael,Miller Kurt

Publisher

Elsevier BV

Subject

Urology

Reference19 articles.

1. The prophylactic value of clean intermittent catheterization and anticholinergic medication in newborns and infants with myelodysplasia at risk of developing urinary tract deterioration;Kasabian;Am J Dis Child,1992

2. Urodynamic effects of oral oxybutynin chloride in children with myelomeningocele and detrusor hyperreflexia;Goessl;Urology,1998

3. The use of intravesical oxybutynin chloride in children with neurogenic bladder;Greenfield;J Urol,1991

4. Complications of intravesical oxybutynin chloride therapy in the pediatric myelomeningocele population;Palmer;J Urol,1997

5. Early cystometrograms can predict the response to intravesical instillation of oxybutynin chloride in myelomeningocele patients;Connor;J Urol,1994

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Guidelines of Patient-Centered Bladder Management of Neurogenic Lower Urinary Tract Dysfunction due to Chronic Spinal Cord Injury - Part 2;Urological Science;2023-01

2. Kurzfassung der S2k-Leitlinie medikamentöse Therapie der neurogenen Dysfunktion des unteren Harntraktes (NLUTD);Die Urologie;2022-10-21

3. Comprehensive overview of the available pharmacotherapy for the treatment of non-neurogenic overactive bladder in children;Expert Opinion on Pharmacotherapy;2022-05-06

4. Aşırı Aktif Mesane Tanısı Alan Çocuklarda Tolterodine Kullanımının Etkisi;Türk Pediatri Arşivi;2020

5. Pharmacologic therapies for the management of non-neurogenic urinary incontinence in children;Expert Opinion on Pharmacotherapy;2019-10-23